DCK and cancer: Ara-C is a prodrug that must be transported within the cancer cells, phosphorylated by deoxycytidine-kinase (DCK) and other kinases to cytarabine-tris-phosphate (ara-CTP), and incorporated into DNA, to be able to exert its anti-proliferative activity (Figure 6) [115].